Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Clinical trial NCT01962103 · COMPLETED

Trial details

NCT number: NCT01962103
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Rhabdomyosarcoma Ewing's Sarcoma Ewing's Tumor Sarcoma, Ewing's Sarcomas, Epitheliod Sarcoma, Soft Tissue Sarcoma, Spindle Cell Melanoma Malignant Melanoma Clinical Oncology Oncology, Medical

Start date: 2013-12-04
Primary completion: 2017-12-05
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.